Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 14Unknown 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Postoperative Cognitive Complications 1Pain, Postoperative 1Pain 1Laryngeal Neoplasms 1Agnosia 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Analgesics, Opioid × Clear all
NCT05857202 2023-05-12

Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer

Clinical Centre of Serbia

Unknown
100 enrolled
Head & Neck

Agnosia, Laryngeal Neoplasms, Pain, Postoperative

NCT03029676 2017-01-24

The Assessment of POCD After TURBT Under Spinal Anesthesia

Medical University of Warsaw

Phase 4 Unknown
200 enrolled
Genitourinary

Postoperative Cognitive Complications, Urinary Bladder Neoplasms

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡